These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 33426092

  • 21. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M, Carbone J, Alecsandru D, Castillo-Rama M, García-Segovia A, Gil J, Alonso B, Aguarón A, Ramos-Medina R, Martínez de María J, Oliver-Miñarro D, Rodríguez-Mahou M, Ortega V, Caballero P, Meliá E, Vidal J, Cianchetta-Sivori M, Esteban C, Vargas-Henny L, Dale J, Ortiz-Quintana L, Fernández-Cruz E, Sánchez-Ramón S.
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [Abstract] [Full Text] [Related]

  • 22. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
    Sung N, Khan SA, Yiu ME, Jubiz G, Salazar MD, Skariah A, Dambaeva S, Kwak-Kim J.
    J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
    [Abstract] [Full Text] [Related]

  • 23. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
    Rogenhofer N, von Schönfeldt V, Ochsenkühn R, Sili F, Thaler CJ.
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
    [Abstract] [Full Text] [Related]

  • 24. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities.
    Kiprov DD, Nachtigall RD, Weaver RC, Jacobson A, Main EK, Garovoy MR.
    Am J Reprod Immunol; 1996 Oct; 36(4):228-34. PubMed ID: 8911631
    [Abstract] [Full Text] [Related]

  • 25. [Application of intravenous immunoglobulin therapy (IVIG) in pregnant patients with recurrent spontaneous abortions].
    Sipak-Szmigiel O, Ronin-Walknowska E, Mikłaszwicz A.
    Ginekol Pol; 2003 May; 74(5):350-5. PubMed ID: 12931461
    [Abstract] [Full Text] [Related]

  • 26. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
    Jafarzadeh S, Ahmadi M, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Kamrani A, Behrad B, Roshangar L, Jadidi-Niaragh F, Yousefi B, Mehdipour M, Farzadi L, Yousefi M.
    J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
    [Abstract] [Full Text] [Related]

  • 27. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
    Egerup P, Kolte AM, Larsen EC, Krog M, Nielsen HS, Christiansen OB.
    Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
    [Abstract] [Full Text] [Related]

  • 28. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
    Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE.
    Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
    [Abstract] [Full Text] [Related]

  • 29. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
    Kwak JY, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE.
    Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
    [Abstract] [Full Text] [Related]

  • 30. Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss.
    Liu H, Lin XX, Huang XB, Huang DH, Song S, Chen YJ, Tang J, Tao D, Yin ZN, Mor G, Liao AH.
    Front Immunol; 2021 Apr; 12():657552. PubMed ID: 34122414
    [Abstract] [Full Text] [Related]

  • 31. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
    Muyayalo KP, Li ZH, Mor G, Liao AH.
    Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
    [Abstract] [Full Text] [Related]

  • 32. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
    Nørgaard-Pedersen C, Nielsen K, Steffensen R, Eriksen L, Jørgensen MM, Kesmodel US, Christiansen OB.
    BMJ Open; 2022 Sep 22; 12(9):e064780. PubMed ID: 36137638
    [Abstract] [Full Text] [Related]

  • 33. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
    Kotlan B, Padanyi A, Batorfi J, Fulop V, Szigetvari I, Rajczy K, Penzes M, Gyodi E, Reti M, Petranyi G.
    Am J Reprod Immunol; 2006 May 22; 55(5):331-40. PubMed ID: 16635207
    [Abstract] [Full Text] [Related]

  • 34. Recurrent pregnancy loss: a disease of inflammation and coagulation.
    Kwak-Kim J, Yang KM, Gilman-Sachs A.
    J Obstet Gynaecol Res; 2009 Aug 22; 35(4):609-22. PubMed ID: 19751318
    [Abstract] [Full Text] [Related]

  • 35. [Intravenous immunoglobulin treatment of recurrent spontaneous abortion with immunopathological background].
    Bátorfi J, Kotlán B, Padányi A, Réti M, Gyódi E, Rajczy K, Miklós K, Németh J, Melicher F, Vályi-Nagy I, Petrányi G, Fülöp V.
    Orv Hetil; 2005 Nov 06; 146(45):2297-302. PubMed ID: 16304808
    [Abstract] [Full Text] [Related]

  • 36. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis.
    Wang SW, Zhong SY, Lou LJ, Hu ZF, Sun HY, Zhu HY.
    Reprod Biomed Online; 2016 Dec 06; 33(6):720-736. PubMed ID: 27720163
    [Abstract] [Full Text] [Related]

  • 37. A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.
    Ensom MH, Stephenson MD.
    Hum Reprod; 2011 Sep 06; 26(9):2283-8. PubMed ID: 21771770
    [Abstract] [Full Text] [Related]

  • 38. Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions.
    Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M.
    Am J Reprod Immunol; 2003 Jan 06; 49(1):21-9. PubMed ID: 12733591
    [Abstract] [Full Text] [Related]

  • 39. Intravenous immunoglobulin in the prevention of recurrent miscarriage: does it work?
    Christiansen OB, Nielsen HS.
    Chem Immunol Allergy; 2005 Jan 06; 88():117-127. PubMed ID: 16129941
    [Abstract] [Full Text] [Related]

  • 40. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO, Gruessner SE, Roberts TK, Tinneberg HR.
    Clin Chem Lab Med; 2004 Apr 06; 42(4):359-70. PubMed ID: 15147144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.